alprenolol has been researched along with sotalol in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (75.86) | 18.7374 |
1990's | 1 (1.72) | 18.2507 |
2000's | 6 (10.34) | 29.6817 |
2010's | 7 (12.07) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Baker, JG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Pfeifer, S; Zimmer, C | 1 |
Hoffman, BF; Rosen, MR; Wit, AL | 1 |
Levy, JV | 1 |
Meier, J | 1 |
Day, MD; Roach, AG | 2 |
Kiechel, JR; Meier, J | 1 |
Baker, I; Das Gupta, DS; Sowton, E | 1 |
Boissier, JR; Giudicelli, JF; Lhoste, F | 1 |
Dubach, UC | 1 |
Prichard, BN | 3 |
Doggrell, SA | 1 |
Fishbein, L; Jackson, CD | 1 |
Turner, P | 1 |
Bak, IJ; Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Goldstein, RE | 1 |
Górka, Z | 1 |
Endoh, M; Hashimoto, K; Kimura, T; Taira, N | 1 |
Carruthers, SG; Kelly, JG; McDevitt, DG; Shanks, RG; Walsh, MJ | 1 |
Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Frankl, WS; Lawrence, T | 1 |
Bergamaschi, M; Caravaggi, AM; Mandelli, V; Shanks, RG | 1 |
Manninen, V | 1 |
Hellenbrecht, D; Lemmer, B; Palm, D; Wiethold, G | 1 |
Garteiz, DA; Walle, T | 1 |
Gettes, LS | 1 |
Simpson, FO | 1 |
Horii, D; Imai, S; Kawada, T; Takeda, K | 1 |
Walle, T | 1 |
Roba, J | 1 |
Saameli, K | 1 |
De Schaepdryver, AF; Lambelin, G; Roba, J | 1 |
Baum, T; Dinish, J; Eckfeld, DK; Metz, N; Peters, JR; Shropshire, AT; Varner, LL | 1 |
Besterman, E; McCarthy, C | 1 |
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
Dean, S; Jack, DB; Kendall, MJ; Laugher, S | 1 |
Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 2 |
Tomov, I | 1 |
Battersby, LA; Cruickshank, JM; Prichard, BN | 1 |
17 review(s) available for alprenolol and sotalol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Biotransformation; Ethanolamines; Humans; Isoproterenol; Kinetics; Levobunolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol | 1975 |
Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Dogs; Electrophysiology; Heart; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Membrane Potentials; Norepinephrine; Propranolol; Purkinje Fibers; Sinoatrial Node; Sotalol | 1975 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
Propranolol in the treatment of angina: a review.
Topics: Alprenolol; Angina Pectoris; Dose-Response Relationship, Drug; Heart Rate; Humans; Isosorbide; Practolol; Propranolol; Sotalol | 1976 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antithyroid Agents; Ethanolamines; Humans; Hyperthyroidism; Iodine Radioisotopes; Oxprenolol; Pindolol; Practolol; Premedication; Propranolol; Sotalol; Sympathomimetics; Thyroidectomy | 1974 |
A comparison of beta-blocking agents.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Dogs; Dose-Response Relationship, Drug; Ethanolamines; Heart; Heart Rate; Humans; Oxprenolol; Propranolol; Propylamines; Sotalol | 1973 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Coronary Circulation; Heart Diseases; Humans; Hypertension; Migraine Disorders; Neurasthenia; Nitroglycerin; Oxprenolol; Pheochromocytoma; Propranolol; Receptors, Adrenergic; Sotalol; Tetralogy of Fallot | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Myocardial Infarction; Oxprenolol; Physical Exertion; Propranolol; Quinidine; Receptors, Adrenergic; Sotalol; Tachycardia, Paroxysmal | 1970 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Ethanolamines; Exercise Test; Heart Rate; Humans; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Sotalol | 1974 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihypertensive Agents; Asthma; Diuretics; Drug Evaluation; Drug Therapy, Combination; Ganglionic Blockers; Heart Failure; Humans; Hypertension; Libido; Oxprenolol; Pindolol; Practolol; Propranolol; Psychopharmacology; Regional Blood Flow; Sotalol; Vasodilator Agents | 1974 |
-Receptor antagonists in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Heart Rate; Humans; Placebos; Propranolol; Sotalol; Sympatholytics | 1971 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Placebos; Practolol; Propranolol; Random Allocation; Sotalol; Time Factors; Timolol | 1984 |
Overdosage with beta-adrenergic blocking agents.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Atropine; Blood Glucose; Cardiovascular System; Central Nervous System; Drug Tolerance; Heart Rate; Humans; Kinetics; Oxprenolol; Pindolol; Propranolol; Respiration; Sotalol | 1984 |
8 trial(s) available for alprenolol and sotalol
Article | Year |
---|---|
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Sotalol | 1975 |
Duration of action of beta-blocking drugs.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Half-Life; Heart Rate; Humans; Physical Exertion; Sotalol; Time Factors | 1973 |
-Receptor antagonists in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Heart Rate; Humans; Placebos; Propranolol; Sotalol; Sympatholytics | 1971 |
Letter: Duration of action of beta-adrenergic blocking drugs.
Topics: Alprenolol; Animals; Clinical Trials as Topic; Heart Rate; Humans; Placebos; Sotalol; Tachycardia; Time Factors; Tritium | 1974 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Placebos; Practolol; Propranolol; Random Allocation; Sotalol; Time Factors; Timolol | 1984 |
37 other study(ies) available for alprenolol and sotalol
Article | Year |
---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Pulse; Rats; Rats, Inbred Strains; Sodium Chloride; Sotalol; Stereoisomerism; Time Factors | 1976 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Beta-adrenergic blockade and atrio--ventricular conduction impairment.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atrioventricular Node; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Pindolol; Practolol; Propranolol; Refractory Period, Electrophysiological; Sotalol; Stereoisomerism | 1975 |
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Vessels; Ethanolamines; Heart; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Sympathomimetics | 1975 |
The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Celiprolol; Electric Stimulation; Ethanolamines; Heart; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Procaterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sotalol | 1990 |
Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Biological Transport; Blood Platelets; Carbon Isotopes; Cell Membrane Permeability; Humans; Kinetics; Microscopy, Electron; Models, Biological; Oxprenolol; Pindolol; Propranolol; Serotonin; Serotonin Antagonists; Sotalol; Tritium | 1972 |
Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Chemical Phenomena; Chemistry; Female; Hemodynamics; Male; Oxprenolol; Pindolol; Propranolol; Sotalol | 1973 |
Comparison of new -andrenergic blockers, C-3, Kö1366, Y-6124 and YB-2, with pindolol and propranolol in the blood perfused canine papillary muscle preparation.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Dogs; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Norepinephrine; Papillary Muscles; Propranolol; Sotalol | 1972 |
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Topics: 1-Propanol; Absorption; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Anesthetics, Local; Animals; Anura; Butylamines; Cresols; Ethanolamines; Heart Conduction System; In Vitro Techniques; Membranes; Nitrobenzenes; Oxprenolol; Phenethylamines; Phenols; Pindolol; Propranolol; Propylamines; Sotalol; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Water | 1973 |
The role of beta adrenoceptors in the coronary and systemic hemodynamic responses to emotional stress in conscious dogs.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Acids; Anesthesia, Intravenous; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Output; Catheterization; Coronary Circulation; Dogs; Electrocardiography; Emotions; Halothane; Heart Rate; Hemodynamics; Humans; Propranolol; Propylamines; Receptors, Adrenergic; Respiration, Artificial; Sotalol; Stress, Psychological; Thiopental | 1973 |
Modified erythrocyte cation permeability.
Topics: Alprenolol; Butylamines; Cell Membrane Permeability; Erythrocytes; Ethanolamines; Humans; Kinetics; Naphthalenes; Nitrobenzenes; Phenethylamines; Potassium; Potassium Isotopes; Propranolol; Sodium; Sodium Isotopes; Sotalol; Stereoisomerism | 1972 |
Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Aniline Compounds; Binding Sites; Blood Proteins; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Membranes; Naphthalenes; Pindolol; Propranolol; Sotalol; Spectrometry, Fluorescence; Sulfonic Acids | 1973 |
Electron impact fragmentation studies of beta-blocking drugs and their metabolites by GC-mass spectroscopy.
Topics: Acetates; Adrenergic beta-Antagonists; Alprenolol; Chemical Phenomena; Chemistry; Chromatography, Gas; Dealkylation; Fluorine; Isoproterenol; Mass Spectrometry; Oxprenolol; Propranolol; Sotalol; Structure-Activity Relationship | 1972 |
Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Butylamines; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Methoxamine; Muscle Contraction; Muscle, Smooth; Oxprenolol; Phenyl Ethers; Pindolol; Practolol; Propanolamines; Propranolol; Receptors, Drug; Sotalol; Trachea | 1974 |
GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Body Fluids; Chromatography, Gas; Ethanolamines; Fluoroacetates; Humans; Isoproterenol; Mass Spectrometry; Myocardium; Oxprenolol; Practolol; Propranolol; Rats; Sotalol | 1974 |
Cardiac toxicity of -lytic drugs.
Topics: 1-Propanol; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Cresols; Ethanolamines; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Indoles; Muscle Contraction; Nitrobenzenes; Oxprenolol; Papaverine; Phenethylamines; Prenylamine; Propranolol; Propylamines; Sotalol; Sympatholytics; Verapamil | 1972 |
Pharmacological characterisation of -receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Ethanolamines; Guinea Pigs; Heart Rate; Isoproterenol; Pindolol; Propranolol; Sotalol | 1972 |
Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Disease Models, Animal; Heart Rate; Hydralazine; Hypertension; Male; Propranolol; Rats; Sotalol | 1972 |
Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Ethanolamines; Levobunolol; Male; Propranolol; Sotalol; Ventricular Fibrillation | 1972 |
Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
Topics: Albuterol; Alprenolol; Animals; Atropine; Bethanidine; Blood Pressure; Cats; Cerebral Ventricles; Clonidine; Dopamine; Epinephrine; Female; Heart Rate; Hexamethonium Compounds; Injections; Isoproterenol; Lidocaine; Male; Norepinephrine; Pempidine; Phentolamine; Practolol; Propranolol; Rabbits; Rats; Receptors, Adrenergic; Sotalol; Species Specificity; Time Factors | 1974 |
Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Chromatography, Thin Layer; Dihydralazine; Humans; Hypertension; Labetalol; Sotalol | 1980 |
Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Humans; Hyperthyroidism; Metoprolol; Middle Aged; Propranolol; Sotalol; Triiodothyronine; Triiodothyronine, Reverse | 1983 |